Analysis of trends in radiofrequency ablation in a tertiary care center practice

Abstract

BackgroundRadiofrequency ablation (RFA) for thyroid nodules has recently been introduced into the United States healthcare system landscape. Little is known about the process of incorporating this procedure into existing clinical practice.MethodsA retrospective chart review of a single institution was conducted to examine referral patterns and decision‐making after the introduction of RFA into an endocrine surgery‐focused practice. Patient demographics and thyroid‐specific data were recorded. Two reviewers abstracted and coded reasons for the noncompletion of RFA. Two‐sample t tests were used to compare groups; linear regression was used to assess trends and practice patterns.ResultsChart review identified 451 patients referred for consideration of RFA from January 2020 to December 2022. Only 255 (56.5%) went on to receive the treatment. There was no significant difference in nodule volume between treated and nontreated groups (18.5 vs. 14.9 cm3, p = 0.07). Concern for malignancy on genetic testing, size (too large/too small), recommendation for Ethanol ablation, and multinodular disease without target nodules were the most common reasons for physician deferral. Of patients who declined to proceed, 46% opted to undergo surgical excision. Linear regression showed that referral numbers significantly increased with time; however, the proportion of patients receiving treatment decreased yearly, primarily because of higher rates of physician deferral.ConclusionsThis study reflects the complex decision‐making in offering minimally invasive thyroid nodule ablation. Despite a greater number of referrals over time, physician criteria became increasingly selective. Optimal candidacy in RFA is an evolving determination requiring patient and physician input to guide ideal practice patterns.